AREDS2 Age-Related Eye Disease Study
The National Eye Institute, a division of the U.S. National Institutes of Health, has invited Notal Vision to sponsor an ancillary study to the second Age-Related Eye Disease Study (AREDS2) using the ForeseeHome™ AMD Monitor. The overall objective of this randomized clinical trial is to determine if home monitoring using the ForeseeHome AMD Monitor improves detection of wet AMD when compared with standard care.
Patients currently enrolled in the AREDS2 study may be eligible to participate in the ForeseeHome study. This ForeseeHome study is also open to eligible patients who are not currently enrolled in AREDS2 at participating sites.
Participants must meet the following eligibility requirements:
|| Experience the ForeseeHome